Efavirenz

Sustiva - API Insight, 2019 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 30, 2019
Health, AIDS, Pharmaceutical, Chemical compounds, Drugs, Organic compounds, Bristol-Myers Squibb, Hepatotoxins, Application programming interface, Technical communication, Efavirenz, Web API

The "Sustiva - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sustiva - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Sustiva - API Insight, 2019 provides product and API manufacturers' details across the globe along with the location.
  • The report gives the clear idea on the country wise DMF filed by worldwide companies related to Sustiva.
  • The report also highlights the patent details of Sustiva.

Sustiva - Drug Insight, 2019 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 13, 2019
Health, AIDS, Pharmaceutical, Drugs, Chemical compounds, Organic compounds, Hepatotoxins, Bristol-Myers Squibb, Business intelligence, Strategic management, Cyclopropanes, Efavirenz, SWOT analysis

The "Sustiva - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sustiva - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
  • Sustiva Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.
  • The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country.
  • In addition to this, the report also provides the SWOT analysis for Sustiva and emerging therapies in this space.